Evidence map›Paper›PMID 27266507›Full record

ArticleBMC cardiovascular disorders2016

Central wave reflection is associated with peripheral arterial resistance in addition to arterial stiffness in subjects without antihypertensive medication.

Matias Wilenius, Antti J Tikkakoski, Anna M Tahvanainen, Antti Haring, Jenni Koskela, Heini Huhtala, Mika Kähönen, Tiit Kööbi, Jukka T Mustonen, Ilkka H Pörsti

Registry-linked trialOpen access · goldAbstract readComparative Study
In one paragraph

Article in BMC cardiovascular disorders, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01742702 (Non-Invasive HaemoDYNAMICs in Primary and Secondary Hypertension), which is not on this map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01742702 unknown statusnot on this map

Non-Invasive HaemoDYNAMICs in Primary and Secondary Hypertension: the DYNAMIC-study

TypeobservationalSponsorTampere UniversityRan2006 to 2025Enrolled2,000ConditionsPrimary Hypertension, Secondary Hypertension, Aortic Stenosis, Renal InsufficiencyArmsNitroglycerin 0.25 mg (single dose, no longer given since January 2017), Salbutamol 400 µg (single dose, no longer given since January 2017), L-arginine (10 min infusion, no longer given since January 2017), Liquorice (2 weeks, glycyrrhizin 290-370 mg daily, no longer given since 2012), Small milk casein-derived polypeptides (12 weeks daily, recordings completed 2011)
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 58 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Matias WileniusSchool of Medicine, Department of Internal Medicine, University of Tampere, Tampere, FIN-33014, Finland. matias.wilenius@fimnet.fi.
Antti J TikkakoskiSchool of Medicine, Department of Internal Medicine, University of Tampere, Tampere, FIN-33014, Finland.
Anna M TahvanainenSchool of Medicine, Department of Internal Medicine, University of Tampere, Tampere, FIN-33014, Finland.
Antti HaringSchool of Medicine, Department of Pharmacological Sciences, University of Tampere, Tampere, Finland.
Jenni KoskelaSchool of Medicine, Department of Internal Medicine, University of Tampere, Tampere, FIN-33014, Finland.
Heini HuhtalaSchool of Health Sciences, University of Tampere, Tampere, Finland.
Mika KähönenSchool of Medicine, Department of Internal Medicine, University of Tampere, Tampere, FIN-33014, Finland.
Tiit KööbiDepartment of Clinical Physiology, Tampere University Hospital, Tampere, Finland.
Jukka T MustonenSchool of Medicine, Department of Internal Medicine, University of Tampere, Tampere, FIN-33014, Finland.
Ilkka H PörstiSchool of Medicine, Department of Internal Medicine, University of Tampere, Tampere, FIN-33014, Finland.
Tampere University · FITampere University · FITampere University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAugmentation index, a marker of central wave reflection, is influenced by age, sex, height, blood pressure, heart rate, and arterial stiffness. However, the detailed haemodynamic determinants of augmentation index, and their relations, remain uncertain. We examined the association of augmentation index with vascular resistance and other haemodynamic and non-haemodynamic factors.

methodsBackground information, laboratory values, and haemodynamics of 488 subjects (239 men, 249 women) without antihypertensive medication were obtained. Indices of central wave reflection, systemic vascular resistance, cardiac function, and pulse wave velocity were measured using continuous radial pulse wave analysis and whole-body impedance cardiography.

resultsIn a regression model including only haemodynamic variables, augmentation index in males and female subjects, respectively, was associated with systemic vascular resistance (β = 0.425, β = 0.336), pulse wave velocity (β = 0.409, β = 0.400) (P < 0.001 for all), stroke volume (β = 0.256, β = 0.278) (P = 0.001 for both) and heart rate (β = -0.150, β = -0.156) (P = 0.049 and P = 0.036). When age, height, weight, smoking habits, and laboratory values were included in the regression model, the most significant explanatory variables for augmentation index in males and females, respectively, were age (β = 0.577, β = 0.557) and systemic vascular resistance (β = 0.437, β = 0.295) (P < 0.001 for all). In the final regression model, pulse wave velocity was not a significant explanatory variable for augmentation index, probably due to the high correlation of this variable with age (Spearman's correlation ≥0.617).

conclusionAugmentation index is strongly associated with systemic vascular resistance in addition to arterial stiffness.

trial registrationClinicalTrials.gov, NCT01742702 .

Indexed as

Models, CardiovascularVascular ResistanceVascular StiffnessAdultAgedAged, 80 and overAge DistributionBlood PressureCardiography, ImpedanceFemaleHeart RateHumansHypertensionLinear ModelsMaleManometryArterial stiffnessAugmentation indexCentral wave reflectionSystemic vascular resistance

Identifiers

PMID27266507
PMCPMC4897906
OpenAlexW2411415247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.